EARLY DIAGNOSTIC AND PROGNOSTIC CRITERIA OF ADVERSE COURSE OF ACUTE CORONARY SYNDROME IN TYPE 2 DIABETES
DOI:
https://doi.org/10.11603/2411-1597.2023.3-4.14551Keywords:
acute coronary syndrome, type 2 diabetes mellitus, insulin resistance, risk factorsAbstract
Introduction. Patients with type 2 diabetes have a 2-fold increased risk of developing coronary heart disease, and the risk of death from it is 2–4 times higher than in patients without carbohydrate metabolism disorders.
The aim of the study – to determine the impact of type 2 diabetes and features of the clinical course, expression of changes in laboratory-instrumental parameters, diagnostic paradigm, prognosis and choice of treatment tactics for patients with acute coronary syndrome (STEMI).
The main part. Acute coronary syndrome (STEMI) against the background of type 2 diabetes mellitus develops significantly more often (in 82.8 % of cases) in young and middle-aged men (up to 60 years old), who by gender prevail over female patients in a ratio of 4.8:1. These patients are characterized by the frequent presence of comorbid conditions (hypertension – in 91.4 %, metabolic syndrome – in 82.9 %, chronic kidney disease – in 30.7 %, chronic obstructive pulmonary disease – in 29.3 %, thyroid dysfunction glands – in 22.7 %) and such and such risk factors for coronary heart disease (and their combinations in 89.3 %), such as atherogenic dyslipidemia – in 96.0 %, tobacco smoking – in 34.7 %, use of excessive doses alcohol – in 32.0 %, burdened heredity regarding coronary heart disease – in 29.3 % and type 2 diabetes – in 61.3 % of patients.
Conclusions. It has been established that acute coronary syndrome (STEMI) against the background of type 2 diabetes is 5 times more likely to develop in middle-aged or young men with comorbid pathologies and multiple risk factors for coronary heart disease, is characterized by multivessel and hemodynamically severe damage to the coronary vessels, a large volume of myocardial necrosis, which determines the atypicality and severity of the course of the disease, a high class of heart failure, a significantly higher frequency of life-threatening complications and a high risk of cardiac death.
References
Ralapanawa, U., & Sivakanesan, R. (2021). Epidemiology and the Magnitude of Coronary Artery Disease and Acute Coronary Syndrome: A Narrative Review. Journal of epidemiology and global health, 11(2), 169-177. DOI: 10.2991/jegh.k.201217.001. DOI: https://doi.org/10.2991/jegh.k.201217.001
Oksak, G.A., & Golovanova, I.A. (2017). Contribution of mortality from cardiovascular disease to overall mortality. Wiadomosci lekarskie (Warsaw, Poland : 1960), 70(3 pt 1), 449-455.
Kovalenko, V.M., & Kornatskyi, V.M. (2021). Stan zdorovya naselennya Ukrayiny ta tretynna medychna dopomoha : posibnyk – The state of health of the people of Ukraine and tertiary medical care: a guide. Kyiv [in Ukrainian].
Khan, M.A.B., Hashim, M.J., King, J.K., Govender, R.D., Mustafa, H., & Al Kaabi, J. (2020). Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends. Journal of epidemiology and global health, 10(1), 107-111. DOI: 10.2991/jegh.k.191028.001. DOI: https://doi.org/10.2991/jegh.k.191028.001
Daryabor, G., Atashzar, M.R., Kabelitz, D., Meri, S., & Kalantar, K. (2020). The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System. Frontiers in immunology, 11, 1582. DOI: 10.3389/fimmu.2020.01582. DOI: https://doi.org/10.3389/fimmu.2020.01582
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England), 392(10159), 1789-1858. DOI: 10.1016/S0140-6736(18)32279-7. DOI: https://doi.org/10.1016/S0140-6736(18)32279-7
Damaskos, C., Garmpis, N., Kollia, P., Mitsiopoulos, G., Barlampa, D., Drosos, A., … Diamantis, E. (2020). Assessing Cardiovascular Risk in Patients with Diabetes: An Update. Current cardiology reviews, 16(4), 266-274. DOI: 10.2174/1573403X15666191111123622. DOI: https://doi.org/10.2174/1573403X15666191111123622
Einarson, T.R., Acs, A., Ludwig, C., & Panton, U.H. (2018). Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovascular diabetology, 17(1), 83. DOI: 10.1186/s12933-018-0728-6. DOI: https://doi.org/10.1186/s12933-018-0728-6
Hostryy koronarnyy syndrom z elevatsiyeyu sehmenta ST: unifikovanyy klinichnyy protokol ekstrenoyi, pervynnoyi, vtorynnoyi (spetsializovanoi), tretynnoyi (vysokospetsializovanoi) medychnoyi dopomohy ta kardioreabilitatsiyi. Nakaz Ministerstva okhorony zdorovia Ukrayiny vid 14 veresnia 2021 r. № 1936 – Unified clinical protocol of emergency, primary, secondary (specialized), tertiary (highly specialized) medical care and cardiorehabilitation. Acute coronary syndrome with ST-segment elevation: Order of the Ministry of Health of Ukraine dated September 14, 2021. No. 1936, 60 p. [in Ukrainian].
Ibanez, B., James, S., Agewall, S., Antunes, M.J., Bucciarelli-Ducci, C., Bueno, H., … ESC Scientific Document Group (2018). 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European heart journal, 39(2), 119-177. DOI: 10.1093/eurheartj/ehx393. DOI: https://doi.org/10.1093/eurheartj/ehx393
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Nursing
This work is licensed under a Creative Commons Attribution 4.0 International License.
